Literature DB >> 8404917

In vitro activity of vancomycin and teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis colonizing catheters.

A Kropec1, J Huebner, M Wursthorn, F D Daschner.   

Abstract

In a quantitative in vitro model the activity of vancomycin and teicoplanin in two concentrations (4 x MBC and 1 mg/l) against Staphylococcus aureus and a slime-producing Staphylococcus epidermidis strain colonizing the internal surface of polyurethane and silicone catheters was studied. In comparison with vancomycin, teicoplanin achieved a significantly greater reduction (p < 0.05) in the counts of Staphylococcus aureus and Staphylococcus epidermidis adhering to both polyurethane and silicone catheters.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8404917     DOI： 10.1007/bf01970962

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  9 in total

Review 1.  Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy.

Authors:  H Anwar; J L Strap; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

2.  Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci.

Authors:  J L Gaillard; R Merlino; N Pajot; O Goulet; J L Fauchere; C Ricour; M Veron
Journal:  JPEN J Parenter Enteral Nutr       Date:  1990 Nov-Dec       Impact factor: 4.016

3.  Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer.

Authors:  R C Evans; C J Holmes
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

4.  Staphylococcal adherence to polyvinyl chloride and heparin-bonded polyurethane catheters is species dependent and enhanced by fibronectin.

Authors:  P B Russell; J Kline; M C Yoder; R A Polin
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

5.  Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces.

Authors:  G D Christensen; W A Simpson; A L Bisno; E H Beachey
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

6.  Prophylaxis, cost and effectiveness of therapy of infections caused by gram-positive organisms in neutropenic children.

Authors:  G S Schaison; F C Decroly
Journal:  J Antimicrob Chemother       Date:  1991-04       Impact factor: 5.790

7.  Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients.

Authors:  B Messing; S Peitra-Cohen; A Debure; M Beliah; J J Bernier
Journal:  JPEN J Parenter Enteral Nutr       Date:  1988 Mar-Apr       Impact factor: 4.016

8.  A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies.

Authors:  S H Lim; M P Smith; N Salooja; S J Machin; A H Goldstone
Journal:  J Antimicrob Chemother       Date:  1991-07       Impact factor: 5.790

9.  Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with beta-lactams and aminoglycosides.

Authors:  A A Fauser; E Lang; G Dölken; K J Bross; J Schmid; F Sörgel
Journal:  Infection       Date:  1991 May-Jun       Impact factor: 3.553
  9 in total
  4 in total

1.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

Review 2.  Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.

Authors:  C M Spencer; H M Bryson
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

3.  Activity of glycopeptides in combination with amikacin or rifampin against Staphylococcus epidermidis biofilms on plastic catheters.

Authors:  A Pascual; E Ramirez de Arellano; E J Perea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-06       Impact factor: 3.267

Review 4.  Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; D H Peters
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.